Classification
Compound class	Antibody
Approved drug?	Yes (source: FDA and EMA (2011))

International Nonproprietary Names
INN number	INN
8568	ipilimumab

Synonyms

MDX-010

MDX-101

MDX-CTLA-4

Yervoy®

Database Links
Specialist databases
IMGT/mAb-DB	180
Other databases
PubChem SID	178103470
Search PubMed clinical trials	ipilimumab
Search PubMed titles	ipilimumab
Search PubMed titles/abstracts	ipilimumab
Wikipedia	Ipilimumab

Comments

Ipilimumab is an anti-CTLA-4 monoclonal antibody. It is likely the subject of patent WO2001014424 [3], as antibody 10D1 which was investigated further, claimed in patent EP1503794 [1]. Ipilimumab is an immune checkpoint inhibitor.